Please Wait.....
Report
Generics North America (NAFTA) Industry Guide 2019-2028
Industry Report I 2024-12-20 I 220 Pages I MarketLine
Generics North America (NAFTA) Industry Guide 2019-2028
Summary
The NAFTA Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume , and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The generics industry within the NAFTA countries had a total market value of $88,125.3 million in 2023.The Canada was the fastest growing country, with a CAGR of 7% over the 2019-23 period.
- Within the generics industry, the US is the leading country among the NAFTA bloc, with market revenues of $74,229.0 million in 2023. This was followed by Canada and Mexico, with a value of $7,717.8 and $6,178.6 million, respectively.
- The US is expected to lead the generics industry in the NAFTA bloc, with a value of $98,531.3 million in 2028, followed by Canada and Mexico with expected values of $10,446.0 and $7,720.0 million, respectively.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the NAFTA generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the NAFTA generics market
- Leading company profiles reveal details of key generics market players' NAFTA operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the NAFTA generics market with five year forecasts by both value and volume
- Compares data from the US, Canada and Mexico, alongside individual chapters on each country
Reasons to Buy
- What was the size of the NAFTA generics market by value in 2023?
- What will be the size of the NAFTA generics market in 2028?
- What factors are affecting the strength of competition in the NAFTA generics market?
- How has the market performed over the last five years?
- How large is the NAFTA generics market in relation to its regional counterparts?
Table of Contents
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 NAFTA Generics
2.1. Industry Outlook
3 Generics in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Generics in Mexico
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Generics in The United States
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Company Profiles
9.1. Teva Pharmaceutical Industries Ltd
9.2. Viatris Inc
9.3. Sun Pharmaceutical Industries Ltd
9.4. Novartis AG
9.5. Sandoz Group AG
9.6. Hikma Pharmaceuticals Plc
9.7. Sanofi
9.8. Les Laboratoires Servier SAS
9.9. Stada Arzneimittel AG
9.10. Bayer AG
9.11. Lupin Ltd
9.12. Aspen Pharmacare Holdings Ltd
9.13. EMS SA
9.14. Eurofarma Laboratorios SA
9.15. Ache Laboratorios Farmaceuticos SA
9.16. Apotex Inc
9.17. Teva Canada Ltd
9.18. Sandoz Canada Inc
9.19. CSPC Pharmaceutical Group Ltd
9.20. Sino Biopharmaceutical Ltd
9.21. Hansoh Pharmaceutical Group Co Ltd
9.22. Dr. Reddy's Laboratories Ltd
9.23. Cipla Ltd
9.24. Aurobindo Pharma Ltd
9.25. PT Kalbe Farma Tbk
9.26. PT Indofarma Tbk
9.27. PT Sanbe Farma
9.28. PT Soho Global Health Tbk
9.29. Friulchem SpA
9.30. DOC Generici SRL
9.31. Recordati SpA
9.32. Daiichi Sankyo Co Ltd
9.33. Towa Pharmaceutical Co Ltd
9.34. Sawai Group Holdings Co Ltd
9.35. Toho Holdings Co Ltd
9.36. Laboratorios Silanes SA de CV
9.37. Pfizer Inc
9.38. Biocad
9.39. R-Pharm
9.40. Pharmstandard
9.41. AstraZeneca Plc
9.42. Bluefish Pharmaceuticals AB
9.43. Navamedic ASA
9.44. Novartis International AG
9.45. Beacons Pharmaceuticals Pte Ltd
9.46. Abbott Laboratories SA
9.47. Adcock Ingram Holdings Ltd
9.48. Dongkook Pharmaceutical Co Ltd
9.49. JW Holdings Corp
9.50. Hanmi Pharmaceuticals Co Ltd
9.51. Dong Wha Pharma Co Ltd
9.52. Esteve Pharmaceuticals SA
9.53. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
9.54. Deva Holding AS
9.55. Sandoz Inc
10 Appendix
10.1. Methodology
10.2. About MarketLine
List of Tables
Table 1: NAFTA countries generics industry, revenue ($m), 2019-28
Table 2: NAFTA countries generics industry, revenue ($m), 2019-23
Table 3: NAFTA countries generics industry forecast, revenue ($m), 2023-28
Table 4: Canada generics market value: $ million, 2018-23
Table 5: Canada generics market volume: % of total pharma volume, 2018-23
Table 6: Canada generics market geography segmentation: $ million, 2023
Table 7: Canada generics market value forecast: $ million, 2023-28
Table 8: Canada generics market volume forecast: % of total pharma volume, 2023-28
Table 9: Canada Size of Population (million), 2019-23
Table 10: Canada real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 11: Canada GDP (Current Prices, $ Billion), 2019-23
Table 12: Canada Inflation, 2019-23
Table 13: Canada Consumer Price Index (Absolute), 2019-23
Table 14: Canada exchange rate, 2018-23
Table 15: Mexico generics market value: $ million, 2018-23
Table 16: Mexico generics market volume: % of total pharma volume, 2018-23
Table 17: Mexico generics market geography segmentation: $ million, 2023
Table 18: Mexico generics market value forecast: $ million, 2023-28
Table 19: Mexico generics market volume forecast: % of total pharma volume, 2023-28
Table 20: Mexico Size of Population (million), 2019-23
Table 21: Mexico real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 22: Mexico GDP (Current Prices, $ Billion), 2019-23
Table 23: Mexico Inflation, 2019-23
Table 24: Mexico Consumer Price Index (Absolute), 2019-23
Table 25: Mexico exchange rate, 2018-23
Table 26: United States generics market value: $ million, 2018-23
Table 27: United States generics market volume: % of total pharma volume, 2018-23
Table 28: United States generics market geography segmentation: $ million, 2023
Table 29: United States generics market value forecast: $ million, 2023-28
Table 30: United States generics market volume forecast: % of total pharma volume, 2023-28
Table 31: United States Size of Population (million), 2019-23
Table 32: United States real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 33: United States GDP (Current Prices, $ Billion), 2019-23
Table 34: United States Inflation, 2019-23
Table 35: United States Consumer Price Index (Absolute), 2019-23
Table 36: United States exchange rate, 2018-23
Table 37: Teva Pharmaceutical Industries Ltd: key facts
Table 38: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 39: Teva Pharmaceutical Industries Ltd: Key Employees
Table 40: Viatris Inc: key facts
Table 41: Viatris Inc: Annual Financial Ratios
Table 42: Viatris Inc: Key Employees
Table 43: Sun Pharmaceutical Industries Ltd: key facts
Table 44: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 45: Sun Pharmaceutical Industries Ltd: Key Employees
Table 46: Novartis AG: key facts
Table 47: Novartis AG: Annual Financial Ratios
Table 48: Novartis AG: Key Employees
Table 49: Sandoz Group AG: key facts
Table 50: Sandoz Group AG: Key Employees
Table 51: Hikma Pharmaceuticals Plc: key facts
Table 52: Hikma Pharmaceuticals Plc: Annual Financial Ratios
Table 53: Hikma Pharmaceuticals Plc: Key Employees
Table 54: Sanofi: key facts
Table 55: Sanofi: Annual Financial Ratios
Table 56: Sanofi: Key Employees
Table 57: Les Laboratoires Servier SAS: key facts
Table 58: Les Laboratoires Servier SAS: Key Employees
Table 59: Stada Arzneimittel AG: key facts
Table 60: Stada Arzneimittel AG: Key Employees
Table 61: Bayer AG: key facts
Table 62: Bayer AG: Annual Financial Ratios
Table 63: Bayer AG: Key Employees
Table 64: Bayer AG: Key Employees Continued
Table 65: Bayer AG: Key Employees Continued
Table 66: Lupin Ltd: key facts
Table 67: Lupin Ltd: Annual Financial Ratios
Table 68: Lupin Ltd: Key Employees
Table 69: Aspen Pharmacare Holdings Ltd: key facts
Table 70: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 71: Aspen Pharmacare Holdings Ltd: Key Employees
Table 72: EMS SA: key facts
Table 73: EMS SA: Key Employees
Table 74: Eurofarma Laboratorios SA: key facts
Table 75: Eurofarma Laboratorios SA: Key Employees
Table 76: Ache Laboratorios Farmaceuticos SA: key facts
Table 77: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 78: Apotex Inc: key facts
Table 79: Apotex Inc: Key Employees
Table 80: Teva Canada Ltd: key facts
Table 81: Teva Canada Ltd: Key Employees
Table 82: Sandoz Canada Inc: key facts
Table 83: Sandoz Canada Inc: Key Employees
Table 84: CSPC Pharmaceutical Group Ltd: key facts
Table 85: CSPC Pharmaceutical Group Ltd: Annual Financial Ratios
Table 86: CSPC Pharmaceutical Group Ltd: Key Employees
Table 87: Sino Biopharmaceutical Ltd: key facts
Table 88: Sino Biopharmaceutical Ltd: Annual Financial Ratios
Table 89: Sino Biopharmaceutical Ltd: Key Employees
Table 90: Hansoh Pharmaceutical Group Co Ltd: key facts
Table 91: Hansoh Pharmaceutical Group Co Ltd: Annual Financial Ratios
Table 92: Dr. Reddy's Laboratories Ltd: key facts
Table 93: Dr. Reddy's Laboratories Ltd: Annual Financial Ratios
Table 94: Dr. Reddy's Laboratories Ltd: Key Employees
List of Figures
Figure 1: NAFTA countries generics industry, revenue ($m), 2019-28
Figure 2: NAFTA countries generics industry, revenue ($m), 2019-23
Figure 3: NAFTA countries generics industry forecast, revenue ($m), 2023-28
Figure 4: Canada generics market value: $ million, 2018-23
Figure 5: Canada generics market volume: % of total pharma volume, 2018-23
Figure 6: Canada generics market geography segmentation: % share, by value, 2023
Figure 7: Canada generics market value forecast: $ million, 2023-28
Figure 8: Canada generics market volume forecast: % of total pharma volume, 2023-28
Figure 9: Forces driving competition in the generics market in Canada, 2023
Figure 10: Drivers of buyer power in the generics market in Canada, 2023
Figure 11: Drivers of supplier power in the generics market in Canada, 2023
Figure 12: Factors influencing the likelihood of new entrants in the generics market in Canada, 2023
Figure 13: Factors influencing the threat of substitutes in the generics market in Canada, 2023
Figure 14: Drivers of degree of rivalry in the generics market in Canada, 2023
Figure 15: Mexico generics market value: $ million, 2018-23
Figure 16: Mexico generics market volume: % of total pharma volume, 2018-23
Figure 17: Mexico generics market geography segmentation: % share, by value, 2023
Figure 18: Mexico generics market value forecast: $ million, 2023-28
Figure 19: Mexico generics market volume forecast: % of total pharma volume, 2023-28
Figure 20: Forces driving competition in the generics market in Mexico, 2023
Figure 21: Drivers of buyer power in the generics market in Mexico, 2023
Figure 22: Drivers of supplier power in the generics market in Mexico, 2023
Figure 23: Factors influencing the likelihood of new entrants in the generics market in Mexico, 2023
Figure 24: Factors influencing the threat of substitutes in the generics market in Mexico, 2023
Figure 25: Drivers of degree of rivalry in the generics market in Mexico, 2023
Figure 26: United States generics market value: $ million, 2018-23
Figure 27: United States generics market volume: % of total pharma volume, 2018-23
Figure 28: United States generics market geography segmentation: % share, by value, 2023
Figure 29: United States generics market value forecast: $ million, 2023-28
Figure 30: United States generics market volume forecast: % of total pharma volume, 2023-28
Figure 31: Forces driving competition in the generics market in the United States, 2023
Figure 32: Drivers of buyer power in the generics market in the United States, 2023
Figure 33: Drivers of supplier power in the generics market in the United States, 2023
Figure 34: Factors influencing the likelihood of new entrants in the generics market in the United States, 2023
Figure 35: Factors influencing the threat of substitutes in the generics market in the United States, 2023
Figure 36: Drivers of degree of rivalry in the generics market in the United States, 2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security